MYC and cancer: Our previous findings not only confirmed the biological relevance of MYC dosage compensation but also raised the question if miRNA sponges targeting the miR-17/92 cluster can overcome MYC dosage compensation and induce selective cytotoxicity in MYC-amplified cancer cells.